AHA scientific statement: Advances and challenges in AI applications for cardiovascular medicine

Artificial intelligence (AI) may transform cardiovascular medicine. For now, though, many challenges remain, and few AI tools have been proven to improve care, according to a new American Heart Association scientific statement published today in Circulation, the Association’s flagship, peer-reviewed journal.

CHMP recommends eight new drug approvals, six label expansions

It was a positive week for the European Medicines Agency’s human medicines committee (CHMP), which recommended the approval of eight new drugs including Takeda’s Fruzaqla

April 27, 2024

How kangaroo mother care can help millions of babies each year

More than one in 10 infants worldwide are born preterm, many with complications: Nearly 1 million die each year. This is the single largest cause

October 12, 2023

Gilead partners with PANTHERx for LIVDELZI distribution

LIVDELZI is intended to be used in combination with ursodeoxycholic acid for PBC patients. Credit: Gilead Sciences, Inc./ Business Wire. Gilead Sciences has formed a

August 19, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.